$210B
Global supplement market, ~9% annual growth
Wednesday, August 26, 2026 · 8:00 PM EDT · Live on Zoom
The market is shifting toward personalized, biomarker-driven care. The providers who move first will define the standard.
Webinar Starts In
The question isn't whether this market grows. It's who captures it.
Global supplement market, ~9% annual growth
Personalized nutrition, growing 2× the category
Biomarker-driven supplements, projected by 2030
Vertically integrated platforms now test, interpret, and recommend — direct to consumer. No physician involved.
From a single at-home test to a formula that's uniquely theirs — updated every quarter.
Compatible with epigenetic data, DNA, and standard blood labs — works with what you're already generating.
Variability in triglyceride response to identical meals between individuals — proving one-size-fits-all supplementation is scientifically indefensible.
Reduction in CRP inflammation with biomarker-guided personalized supplement protocols — across all age groups tested, in 12 weeks.
Same category. Different operating system.
One-size-fits-all bottles
Personalize formula built for that patient, dosed to the milligram
Marketing claims, generic RDAs
Epigenetics + blood biomarkers, 900k methylation sites
5–12 pills a day, pill fatigue
One daily pod, 28-day cycle
None — patient buys retail
Full patient panel: biomarkers, adherence, epigenetic age
Static — same formula for years
Quarterly retest and re-formulation
$0 — you’re cut out
30% recurring commission on every pod
We removed the entry tiers. The Biohax HCP Program is EET™ Guided — the deepest level of personalization, and the only version that gives you a clinical panel of your patient.
Protocol built from epigenetics and blood biomarkers. Refined quarterly. The only pod in the market this personalized.
A live session covering the full Biohax clinical model, the provider partnership structure, and what this means for your practice and your revenue.
No cost. A recording goes out to everyone who registers.